Finance

Lists
NBTX:NASDAQ
Nanobiotix SA - ADR
$25.23
+0.52%
(+0.13) 1D
$25.23
0.00% (0.00)
After hours
Closed: Oct 6, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NBTX...
Open
$25.69
High
$25.69
Low
$24.16
Mkt. cap
1.31B
Avg. vol.
157.90K
Volume
8.00
52-wk high
$57.14
52-wk low
$14.78
EPS
-$1.22
Beta
0.74
Shares outstanding
50.62M
No. of employees
98
Open
$25.69
High
$25.69
Low
$24.16
Mkt. cap
1.31B
Avg. vol.
157.90K
Volume
8.00
52-wk high
$57.14
52-wk low
$14.78
EPS
-$1.22
Beta
0.74
Shares outstanding
50.62M
No. of employees
98
News stories
From web sources and news partners
Profile
Nanobiotix is a biotechnology company that uses nanomedicine to develop new radiotherapy techniques for cancer patients. The company is headquartered in Paris, with additional corporate offices in New York and Massachusetts. Wikipedia
About Nanobiotix SA - ADR
CEOLaurent Levy
Employees98
Founded2003
Headquarters-
SectorBiotechnology
Analyst ratings
Based on 3 analysts giving stock ratings to NBTX in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for NBTX in the last 3 months.
Highest
Current $25.23
$64.00 (+153.67%)
Average
$47.00 (+86.29%)
Lowest
$30.00 (+18.91%)
Analyst
Recommendation
Action
Price target
Projected
Date
Paul Jeng
Guggenheim
Buy
Maintained
$64.00
+153.7%
09/25/2026
David Dai
UBS
Hold
Maintained
$30.00
+18.9%
09/25/2026
Tara Bancroft
TD Cowen
Buy
Maintained
-
-
09/25/2026
Michael Schmidt
Guggenheim
Buy
Reiterated
$36.00
+42.7%
05/05/2026
Jonathan Chang
Leerink Partners
Buy
Maintained
$37.00
+46.7%
04/01/2026
Unknown Analyst
Guggenheim
Buy
Maintained
$26.00
+3.1%
02/05/2026
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.98M
2.98M
2.78M
2.78M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4.29M
4.29M
6.36M
6.36M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.53M
4.53M
5.38M
5.38M
Operating expense
8.83M
8.83M
11.74M
11.74M
Total operating expenses
8.83M
8.83M
11.74M
11.74M
Operating income
-5.85M
-5.85M
-8.96M
-8.96M
Other non operating income
-8.50K
-8.50K
-1.00K
-1.00K
EBT including unusual items
-9.29M
-9.29M
-17.14M
-17.14M
EBT excluding unusual items
-8.57M
-8.57M
-16.56M
-16.56M
Income tax expense
-1.50K
-1.50K
8.00K
8.00K
Effective tax rate
0.02%
0.02%
-0.05%
-0.05%
Other operating expenses
-
-
-
-
Net income
-9.29M
-9.29M
-17.14M
-17.14M
Net profit margin
-311.97%
-311.97%
-617.69%
-617.69%
Earnings per share
-
-
-
-
Interest and investment income
193.50K
193.50K
338.50K
338.50K
Interest expense
-3.08M
-3.08M
-7.28M
-7.28M
Net interest expenses
-2.88M
-2.88M
-6.94M
-6.94M
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.79M
-5.79M
-8.84M
-8.84M
Gain or loss from assets sale
76.50K
76.50K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google apps